Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Lilly designs selective 5-HT1A antagonists especially for nicotine/tobacco withdrawal

July 12, 1999

LecTec granted patents on cotinine for smoking cessation and psychiatric disorders

July 7, 1999

Orphan Medical's Antizol injection receives approval in the U.K.

June 29, 1999

Cantab's vaccine for cocaine addiction shows encouraging phase I results

June 18, 1999

M-100907: a potential treatment for coexisting cocaine dependence and schizophrenia

May 26, 1999

Systematic review of published studies questions efficacy of carbamazepine in cocaine dependency

May 26, 1999

Slow-release naltrexone enters the clinic

April 29, 1999

Nabi nicotine vaccine shows promise in preclinical studies

April 22, 1999

Immunization strategy effectively blocks the behavioral effects of cocaine in monkeys

April 22, 1999

U. Penn team synthesizes novel analogues of Ritalin for treatment of cocaine addiction

April 9, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...